Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00588822	Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance	terminated	Phase 2	21	Mayo ClinicOTHER	1	May 6, 2014	clinicaltrials
NCT00899353	Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)	terminated	Phase 2	16	Marshall UniversityOTHER	1	Dec 12, 2013	clinicaltrials